1.4.4 South America , Middle East and Africa 1.4.4.1 Brazil Market States and Outlook ( 2012-2022 ) 1.4.4.2 Egypt Market States and Outlook ( 2012-2022 ) 1.4.4.3 Saudi Arabia Market States and Outlook ( 2012-2022 ) 1.4.4.4 South Africa Market States and Outlook ( 2012-2022 ) 1.4.4.5 Nigeria Market States and Outlook ( 2012-2022 ) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Sanofi 2.1.1 Business Overview 2.1.2 Gaucher Disease Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Sanofi Gaucher Disease Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.2 Shire 2.2.1 Business Overview 2.2.2 Gaucher Disease Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Shire Gaucher Disease Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.3 Actelion Pharma 2.3.1 Business Overview 2.3.2 Gaucher Disease Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Actelion Pharma Gaucher Disease Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Gaucher Disease Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Pfizer Gaucher Disease Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.5 ISU Pharm 2.5.1 Business Overview 2.5.2 Gaucher Disease Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 ISU Pharm Gaucher Disease Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 3 Global Gaucher Disease Market Competition , by Manufacturer 3.1 Global Gaucher Disease Sales and Market Share by Manufacturer 3.2 Global Gaucher Disease Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Gaucher Disease Manufacturer Market Share 3.3.2 Top 6 Gaucher Disease Manufacturer Market Share 3.4 Market Competition Trend